Westpac Banking Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Westpac Banking Corp’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-82,342	Closed	-$729K	–	747
2023 Q1	$729K	Hold	82,342	–	–	0.01%	700
2022 Q4	$751K	Hold	82,342	–	–	0.01%	653
2022 Q3	$665K	Hold	82,342	–	–	0.01%	680
2022 Q2	$619K	Hold	82,342	–	–	0.01%	730
2022 Q1	$773K	Hold	82,342	–	–	0.01%	727
2021 Q4	$660K	Hold	82,342	–	–	0.01%	755
2021 Q3	$802K	Hold	82,342	–	–	0.01%	754
2021 Q2	$815K	Hold	82,342	–	–	0.01%	779
2021 Q1	$950K	Hold	82,342	–	–	0.01%	702
2020 Q4	$795K	Hold	82,342	–	–	0.01%	764
2020 Q3	$742K	Hold	82,342	–	–	0.01%	724
2020 Q2	$1.02M	Hold	82,342	–	–	0.02%	631
2020 Q1	$739K	Hold	82,342	–	–	0.01%	657
2019 Q4	$807K	Hold	82,342	–	–	0.01%	730
2019 Q3	$567K	Buy	+82,342	New	+$631K	0.01%	761
2019 Q1	–	Sell	-82,342	Closed	-$1.27M	–	803
2018 Q4	$1.27M	Buy	+82,342	New	+$1.69M	0.02%	536
2017 Q4	–	Sell	-59,039	Closed	-$1.04M	–	776
2017 Q3	$1.04M	Buy	+59,039	New	+$1.33M	0.02%	501
2017 Q2	–	Sell	-63,979	Closed	-$2.05M	–	916
2017 Q1	$2.05M	Buy	+63,979	New	+$2.18M	0.02%	555
2016 Q3	–	Sell	-8,704	Closed	-$437K	–	864
2016 Q2	$437K	Buy	+8,704	New	+$463K	﹤0.01%	754
2015 Q2	–	Sell	-258,088	Closed	-$16.1M	–	932
2015 Q1	$16.1M	Buy	258,088 +19,500	+8%	+$1.13M	0.14%	160
2014 Q4	$13.7M	Buy	238,588 +12,390	+5%	+$690K	0.13%	177
2014 Q3	$12.2M	Hold	226,198	–	–	0.12%	183
2014 Q2	$11.9M	Buy	+226,198	New	+$11.6M	0.11%	186
2014 Q1	–	Sell	-490,628	Closed	-$19.7M	–	903
2013 Q4	$19.7M	Buy	490,628 +78,700	+19%	+$3.1M	0.23%	112
2013 Q3	$15.6M	Buy	+411,928	New	+$16.1M	0.19%	130

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Westpac Banking Corp's TEVA Position: Q2 2023 in Review

Westpac Banking Corp sold out of Teva Pharmaceuticals (TEVA) in Q2 2023, closing a stake of 82,342 shares — an estimated $729K sold.

Westpac Banking Corp first reported a position in TEVA in Q3 2013 and held it in 25 quarters. The position peaked at $19.7M in Q4 2013. 428 funds tracked by Wall St. Rank hold TEVA as of Q2 2023.

Westpac Banking Corp reported no remaining Teva Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Westpac Banking Corp sold 82,342 Teva Pharmaceuticals shares in Q2 2023, an estimated $729K.
Westpac Banking Corp first reported a position in Teva Pharmaceuticals in Q3 2013 and held it in 25 quarters.
Westpac Banking Corp's Teva Pharmaceuticals position peaked at $19.7M in Q4 2013.
428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2023.

Based on Westpac Banking Corp's 13F filing for Q2 2023, filed 10 Aug 2023.